This investigate was carried out To guage the prospective of your CPPs with tumor-targeting Attributes to deliver a cytotoxic payload to HCC cells. We explored using a CXCR4-targeting peptide, T22, fused with cytotoxic peptide PE24, as a novel therapeutic tactic for CXCR4+ HCC cells. T22 was picked as the nanocarrier https://gastonc963kos4.newbigblog.com/profile